NORTEM BIOGROUP
Research NORTEM BIOGROUP (MLBIO.PA) on Bullrun: market cap EUR 13.92M, P/E 28.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMLBIO.PA
- ExchangeXMLI
- CurrencyEUR
- Market capEUR 13.92M
- P/E28.4
- Financial periodFY2023
- RevenueEUR 7.20M
- Revenue growth3.1%
- Net incomeEUR 416.80K
- Free cash flow-EUR 1.93M
- Gross margin92.3%
Valuation Snapshot
latest market cap is EUR 13.92M; P/E is 28.4.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2023 | EUR 7.20M | EUR 416.80K | -EUR 1.93M | 92.3% | n/a | EUR 367.09K | EUR 5.41M | EUR 6.90M |
| FY2022 | EUR 6.98M | EUR 500.25K | -EUR 2.13M | 92.0% | 0.19 | EUR 65.37K | EUR 3.86M | EUR 6.62M |
| FY2021 | EUR 6.79M | EUR 564.18K | n/a | 82.7% | 0.22 | EUR 60.70K | EUR 3.86M | EUR 5.14M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-11 | EUR 13.92M | 28.4 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
Related stock research
Frequently asked questions
What is NORTEM BIOGROUP's market cap?
NORTEM BIOGROUP's market capitalization is EUR 13.92M.
What is NORTEM BIOGROUP's P/E ratio?
NORTEM BIOGROUP's price-to-earnings (P/E) ratio is 28.4.